← Eichor
Condition: Therapy Associated Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Therapy Associated Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03535246Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
NA · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT07399977MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myel
Phase N/A · 2 location(s) · MPN Research Foundation · NCT07362225A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive
Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT07443943Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome
Phase N/A · 10 location(s) · Fresenius Kabi · NCT06274788Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms
EARLY_Phase 1 · 2 location(s) · Philip Chang · NCT06123286EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
Phase 1 · 4 location(s) · Baylor College of Medicine · NCT04664179Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infec
Phase 1/Phase 2 · 1 location(s) · LucasBio · NCT07670468Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Phase 2 · 1 location(s) · KTH Biopharma · NCT07698886Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Phase 1 · 7 location(s) · AIDS Malignancy Consortium · NCT05077527Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients W
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06904066Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leuke
Phase 2 · 1 location(s) · Northside Hospital, Inc. · NCT05519579Role of Pro-Resolving Lipid Mediators in Obesity-Associated Diseases
Phase N/A · 2 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT07447440A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06984861HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Phase 1 · 1 location(s) · Hangzhou Polymed Biopharmaceuticals, Inc. · NCT07137637A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06736613A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program f
NA · 1 location(s) · Mayo Clinic · NCT06831838Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta
Phase 2 · 88 location(s) · National Cancer Institute (NCI) · NCT06029270Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma
Phase 3 · 1 location(s) · University of Sao Paulo · NCT07381972An Exploratory Study on Microbial Biomarkers Associated With the Efficacy of Neoadjuvant Therapy
Phase N/A · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07263620Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer
Phase N/A · 1 location(s) · Fudan University · NCT06503380A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05491512A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Pre
Phase 3 · 62 location(s) · Grifols Therapeutics LLC · NCT05645107PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Mult
NA · 6 location(s) · Centre Leon Berard · NCT05947136Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevan
Phase N/A · 1 location(s) · Ottawa Hospital Research Institute · NCT06894576A Registry Study on HIV-related Lymphoma
Phase N/A · 6 location(s) · Rotkreuzklinikum München gGmbH · NCT05231135This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT07160270Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatm
Phase 1/Phase 2 · 1 location(s) · Beijing Tongren Hospital · NCT07525466
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.